Literature DB >> 6132336

The natural history of the inherited methylmalonic acidemias.

S M Matsui, M J Mahoney, L E Rosenberg.   

Abstract

Six biochemical and genetic forms of methylmalonic acidemia have been defined previously: two (mut degrees and mut-) resulting from defects in the mutase apoenzyme, and four (cbl A, cbl B, cbl C, and cbl D) resulting from deficient adenosylcobalamin synthesis. We retrospectively surveyed the clinical presentation, response to cobalamin supplementation, and long-term outcome in the four most prevalent mutant classes by collecting detailed information on 45 patients (15 mut degrees, 5 mut-, 14 cbl A, and 11 cbl B). Most patients presented acutely with a common set of clinical and laboratory findings; however, there were significant differences between mutant classes: mut degrees patients presented earlier in infancy than did cbl A and cbl B patients; in response to cobalamin supplements, marked decreases in the concentration of methylmalonic acid in blood or urine were reported in most cbl A patients and in nearly half the cbl B patients, but not in mut degrees or mut- patients; and finally, most cbl A, cbl B, and mut- patients were still living, whereas most mut degrees patients died during the first few months of life. Our data indicate that genotypic classification of the methylmalonic acidemias has prognostic and therapeutic use as well as diagnostic value.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6132336     DOI: 10.1056/NEJM198304143081501

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  94 in total

1.  FGF21 underlies a hormetic response to metabolic stress in methylmalonic acidemia.

Authors:  Irini Manoli; Justin R Sysol; Madeline W Epping; Lina Li; Cindy Wang; Jennifer L Sloan; Alexandra Pass; Jack Gagné; Yiouli P Ktena; Lingli Li; Niraj S Trivedi; Bazoumana Ouattara; Patricia M Zerfas; Victoria Hoffmann; Mones Abu-Asab; Maria G Tsokos; David E Kleiner; Caterina Garone; Kristina Cusmano-Ozog; Gregory M Enns; Hilary J Vernon; Hans C Andersson; Stephanie Grunewald; Abdel G Elkahloun; Christiane L Girard; Jurgen Schnermann; Salvatore DiMauro; Eva Andres-Mateos; Luk H Vandenberghe; Randy J Chandler; Charles P Venditti
Journal:  JCI Insight       Date:  2018-12-06

2.  Successful dialysis in a boy with methylmalonic acidemia.

Authors:  Kyung Hoon Paik; Ji Eun Lee; Dong-Kyu Jin
Journal:  Pediatr Nephrol       Date:  2004-02-21       Impact factor: 3.714

3.  Methylmalonic and propionic acidurias: management without or with a few supplements of specific amino acid mixture.

Authors:  G Touati; V Valayannopoulos; K Mention; P de Lonlay; P Jouvet; E Depondt; M Assoun; J C Souberbielle; D Rabier; H Ogier de Baulny; J-M Saudubray
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

4.  Differential diagnosis of mut and cbl methylmalonic aciduria by DNA-mediated gene transfer in primary fibroblasts.

Authors:  M F Wilkemeyer; A M Crane; F D Ledley
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

5.  Isovaleric, methylmalonic, and propionic acid decrease anesthetic EC50 in tadpoles, modulate glycine receptor function, and interact with the lipid 1,2-dipalmitoyl-Sn-glycero-3-phosphocholine.

Authors:  Yun Weng; Tienyi Theresa Hsu; Jing Zhao; Stefanie Nishimura; Gerald G Fuller; James M Sonner
Journal:  Anesth Analg       Date:  2009-05       Impact factor: 5.108

6.  Mild form of methylmalonic aciduria misdiagnosed as propionic acidaemia during a ketotic crisis.

Authors:  I T de Almeida; M Duran; M F Silva; R Portela; A Cabral; T Tasso; F Eusébio; C Silveira
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

7.  Neurological outcome of methylmalonic acidaemia.

Authors:  P Nicolaides; J Leonard; R Surtees
Journal:  Arch Dis Child       Date:  1998-06       Impact factor: 3.791

8.  Enamel defects and salivary methylmalonate in methylmalonic acidemia.

Authors:  C W Bassim; J T Wright; J P Guadagnini; R Muralidharan; J Sloan; D L Domingo; C P Venditti; T C Hart
Journal:  Oral Dis       Date:  2009-01-09       Impact factor: 3.511

9.  Treatment of the cbl B form of methylmalonic acidaemia with adenosylcobalamin.

Authors:  M L Batshaw; G H Thomas; S R Cohen; R Matalon; M J Mahoney
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

10.  Hudson memorial lecture. Neonatal management of organic acidurias. Clinical update.

Authors:  J M Saudubray; H Ogier; C Charpentier; E Depondt; F X Coudé; A Munnich; G Mitchell; F Rey; J Rey; J Frézal
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.